Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015

Similar documents
IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING

What is sepsis? RECOGNITION. Sepsis I Know It When I See It 9/21/2017

Staging Sepsis for the Emergency Department: Physician

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN

Core Measures SEPSIS UPDATES

Inflammatory Statements

OHSU. Update in Sepsis

BC Sepsis Network Emergency Department Sepsis Guidelines

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health

Sepsis and Antimcrobial Stewardship: Are they really mutually Exclusive?

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

John Park, MD Assistant Professor of Medicine

No conflicts of interest to disclose

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Sepsis Care and the New Core Measures. Daniel S. Hagg, MD January 15, 2016

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

Sepsis 3.0: The Impact on Quality Improvement Programs

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign

Sepsis care and the new core measures

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

SURVIVING SEPSIS: Early Management Saves Lives

Sepsis: Identification and Management in an Acute Care Setting

Understand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the

SUCCESS IN SEPSIS MORTALITY REDUCTION. Maryanne Whitney RN MSN CNS Improvement Advisor, Cynosure Health HRET HEN AK Webinar

Increased female mortality after ICU admission and its potential causes.

Sepsis and Septic Shock: New Definitions for Adults

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

3 papers from ED. counting sepsis sepsis 3 wet or dry?

Early Recognition and Timely Management of Sepsis Amid Changes in Definitions

Is nosocomial infection the major cause of death in sepsis?

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Sepsis Learning Collaborative: Sepsis New Definitions

Sepsis Awareness and Education

Sepsis. Reliability- can we achieve Dr Ron Daniels

Sepsis: What Is It Really?

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.

Nothing to disclose 9/25/2017

9/25/2017. Nothing to disclose

Supplementary Online Content

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

Key Points. Angus DC: Crit Care Med 29:1303, 2001

Updates in Emergency Department Management of Sepsis

Guidelines are the Future of Sepsis Management Pro

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

Augmented Renal Clearance: Let s Get the Discussion Flowing

Severe Sepsis/ Septic Shock. Fereshte Sheybani, MD. Assistant Professor in Infectious Diseases

JAMA. 2016;315(8): doi: /jama

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

MAKING SENSE OF IT ALL AUGUST 17

Fluorescence immunoassay Point of care test Wide range PCT. whole blood. plasma. serum

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

SEPSIS & SEPTIC SHOCK

Sepsis Management: Past, Present, and Future

Early Goal-Directed Therapy

Last frontier of infection in critically ill patients

Sepsis - A Year in Transition

SEPSIS UPDATE WHY DO WE NEED A CORE MEASURE CHAD M. KOVALA DO, FACOEP, FACEP

CURRENT GUIDELINES FOR SEPSIS MANAGEMENT

Community Acquired Pneumonia: Measures to Improve Management and Healthcare Quality

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018

Current State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018

Diagnosis and Management of Sepsis. Disclosures

DELIRIUM IN SEPSIS. Professor Kevin Rooney: National Clinical Lead for Sepsis Alison Hunter: Improvement Advisor, Sepsis Collaborative

The Sepsis Timebomb. James Wigfull Critical Care and Anaesthesia Sheffield Teaching Hospitals

Pneumonia in the Hospitalized

Text-based Document. Implications of the Sepsis-3 Definition on Nursing Research and Practice. Authors Peach, Brian C. Downloaded 5-Jul :03:48

Initial Resuscitation of Sepsis & Septic Shock

Educational Workshop

The changing face of

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Sepsi: nuove definizioni, approccio diagnostico e terapia

JMSCR Vol 05 Issue 06 Page June 2017

Paramedic Initiated Prehospital CMS Sepsis Core Measures. Jason Walchok NRP, FP-C Training Coordinator, Greenville County EMS

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

Community-Acquired Pneumonia OBSOLETE 2

Updates in Sepsis 2017

A BRIEF HISTORY OF SEPSIS. Euan Mackay

Inpatient Quality Reporting Program

Does this patient need ICU?

Retrospective study; only patients w/lactate > 4. Initial Lactate: Did not address

Outpatient treatment in women with acute pyelonephritis after visiting emergency department

Serum lactate is an independent predictor of hospital mortality in critically ill patients in the emergency department: a retrospective study

Sepsis in primary care. what is good care?

Sepsis Denials. Presented by James Donaher, RHIA, CDIP, CCS, CCS-P

UPDATE IN HOSPITAL MEDICINE

ADVANCES IN BIOMARKER TESTING FOR SEPSIS AND BACTERIAL INFECTIONS

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

Inpatient Quality Reporting (IQR) Program

Impact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department

Appendix. Supplementary figures and tables

Sepsis. Current Dilemmas in Diagnosing Sepsis. Chapter 2

Use of Blood Lactate Measurements in the Critical Care Setting

Early lactate clearance rate is an indicator of Outcome in severe sepsis and septic shock

The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya

towards early goal directed therapy

Relationship between Age and Peripheral White Blood Cell Count in Patients with Sepsis

Guidelines. 14 Nov Marc Bonten

Transcription:

The TIMES Project: (Time to Initiation of Antibiotic Therapy in Medical Patients Presenting to the Emergency Department with Sepsis) - Preliminary Findings Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015

Disclosures No conflicts of interest to disclose.

Background Delays in initiation of appropriate antimicrobial therapy play a substantial role in determining the mortality of patients with sepsis and septic shock. Kumar et al. (2006): The delay to initial administration of effective antimicrobial therapy is the single strongest predictor of survival, with significant decreases in projected patient survival for every hour of antibiotic delay. 1 1 Kumar et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.crit Care Med. 2006 Jun;34(6):1589-96.

A New Golden Hour

Implications of Sepsis in the ED Literature pertaining to Sepsis management in the Critical Care Environment is robust Fewer studies addressing sepsis management in the ED Two studies demonstrate that delays in initiation of appropriate antibiotic therapy of > 6-8 hours, after triage, has led to increased mortality 2-3 2 Meehan et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997 Dec 17;278(23):2080-4 3 Puscharich et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med. 2011 Sep;39(9):2066-71.

TIMES Study Rationale We hypothesized that there are substantial delays between patient presentation, medical evaluation, and effective antimicrobial administration in patients presenting to the Emergency Department of our institution.

TIMES Project: 2 Step Process Step I: Medical Audit Purpose: To examine the time to initiation of appropriate antimicrobial therapy in medical patients presenting to the Emergency Department (ED) with sepsis. Step II: Intervention Purpose: Implementation of an early sepsisidentification/antibiotic-delivery protocol in order to : Facilitate the recognition of deteriorating ED patients with sepsis Expedite the delivery of appropriate broad-spectrum antimicrobial therapy.

TIMES AUDIT

Part 1: TIMES Audit A retrospective chart review of medical patients presenting to the ED with sepsis. Location: Montreal General Hospital Dates: July 1, 2013 and June 30, 2014

Defining Sepsis: SIRS Criteria (2/4): Temp >38 C (100.4 F) or < 36 C (96.8 F) HR > 90 RR > 20 or PaCO 2 <32 mmhg WBC > 12,000/mm> 3, < 4,000/mm> 3, or > 10% bands *** with documented or presumed infection. 4. "American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis" (PDF). Crit. Care Med. 20(6): 864 74.

Audit Structure Patient Selection Total Admissions from ED to Medical CTU (Direct) Total Admissions where Antibiotics were Initiated in the ED for presumed Infection Total Medical Admissions from ED to ICU Total Admissions meeting criteria for Sepsis

Study Objectives Primary outcomes: Time to first dose of appropriate antibiotic In-hospital mortality Secondary outcomes: Length of hospitalization 30-Day Mortality Rate of subsequent ICU Admission For patients admitted to CTU directly from the ED

Appropriate Antibiotic Selection We also reviewed the appropriateness of initial antibiotic selection by reviewing culture results and/or chart-review of the working diagnosis at the time of antibiotic administration. Appropriateness criteria were extracted from IDSA Guidelines/Recommendations and McGill University Health Centre Antibiotic Guidelines.

Audit Structure Patient Selection Total Admissions from ED to Medical CTU (Direct) n=1520 Total Admissions where Antibiotics were Initiated in the ED for presumed Infection n=712 n=326 Total Medical Admissions from ED to ICU Total Admissions meeting criteria for Sepsis n=272

Table 1: Baseline Characteristics for Patients while in the ED (1) CHARACTERISTIC (n = 272) AGE 73.1±17.4 SEX % Female Male 54.4 45.6

Table 1: Baseline Characteristics (2) VARIABLES (n = 272) HEART RATE (beats/min) 114±27 SYSTOLIC BLOOD PRESSURES (mmhg) 106±31 RESPIRATORY RATE (breaths/min) 23±4 TEMPERATURE (Degree Centrigrade) 37.4±2.1 WBC (per mm2) 13.6±8.3 Lactate (mmol/l) 2.6±1.9 Creatinine (mmol/l) 194±24 Sodium (mmol/l) 135±3.8 Potassium (mmol/l) 4.8±0.6 Glucose (mmol/l) 8.3±4.2 Hematocrit 0.336±0.102

TIMES Audit: Working Diagnoses WORKING DIAGNOSIS % Pneumonia Urosepsis/UTI Cellulitis/Nec Fasc Septic Arthritis Peritonitis Meningitis/Encephalitis Other OR Uncertain Primary Source n=272 36.8 26.2 14.6 7.2 2.6 2.5 10.1

TIMES Audit: Antibiotics Utilized Antibiotic Usage 3rd and 4th Generation Cephalosporins 11% Other 39% 8% 5% 5% 5% Quinolones Carbapenems 27% Macrolides 2 Antibiotics 3 or More Antibiotics

TIMES Audit: Antibiotic Appropriateness Antibiotic Appropriateness 22% 78% * Cultures were drawn prior to ABX initiation for 74 % of patients Percent Appropriate Percent Inappropriate

RESULTS PRIMARY OUTCOMES Median delay from presentation to initiation of antibiotics was 4.2 hours (IQR 1.2h 12.4h). In-hospital mortality was 6.8%. For the ICU Cohort: In-hospital mortality was 12.8% Increased mortality was observed with each additional hour of antibiotic delay Odds ratio for mortality for >3 hour delay in appropriate antibiotic administration was 3.21 (95% CI 1.25-9.28). SECONDARY OUTCOMES Average length of stay was 9.1 days 30-Day Mortality was 7.6% Subsequent ICU Admission for patients originally admitted to CTU: 5.9% (IQR 5.1%-7.0%).

TIMES INTERVENTION

Step 2: TIMES Intervention Purpose: Implementation of an early sepsisidentification/antibiotic-delivery protocol in our Emergency Department.

Intervention Planning: Education Educational POD sessions were organized between members of our team and stake-holders (ED staff physicians and nurses, pharmacists, and Internal Medicine (IM) physicians working in the Emergency Department in a gate-keeping capacity) during the three months prior to the implementation date of our protocol. Go Live: May 2015

Sample Protocol (Page 1)

Sample Protocol (Page 2)

RESULTS (1) A prospective observational study to assess outcomes after protocol initiation is presently underway For data collected over a ~ 3 month period: CHARCTERISTICS/VARIABLES (n=48) Intervention (n = 272) Control AGE 74.1±15.2 73.1±17.4 SEX % Female Male 52.2 47.8 54.4 45.6 HEART RATE (beats/min) 112±17 114±27 SYSTOLIC BLOOD PRESSURES (mmhg) 114±26 106±31 RESPIRATORY RATE (breaths/min) 21±3 23±4 TEMPERATURE (Degree Centrigrade) 37.2±1.8 37.4±2.1

RESULTS (2) Appropriate Initial Antibiotic Usage increased from 78% to 86%. Preliminary results suggest a reduction in the time to appropriate antibiotic initiation of 1.8 hours (IQR 0.4h-2.3h) post-intervention. In-hospital mortality decreased from 6.8% to 5.5%.

More Work on the Horizon Continuation of Project in ED (Medicine + Primary ED Team) Introduction of Protocol to CTU Sub-Analyses of times based on hour of presentation to the ED (AM vs. PM) and ED occupancy

Conclusions The delay to initial administration of effective antimicrobial therapy is the single strongest predictor of survival. Our work suggests the benefit of instituting a rapid, low-cost, protocol-based system to improve empiric management of sepsis. Such a protocol has potential for subsequent implementation on other units (ie: Medical and Surgical Clinical Teaching Units), which could further improve outcomes.

ACKNOWLEDGEMENTS Thanks to: Christina Weisstock and Maxime Billick MED 3, McGill University Ling Kong, MDCM, Infectious Disease Fellow, McGill University Dev Jayaraman, MDCM, FRCPC, MPH, Associate Professor, General Internal Medicine and Critical Care, McGill University McGill GIM Residency Program Scholarly Activity Enrichment Fund